RJA
APHA

Raymond James & Associates’s Aphria Inc. Common Shares APHA Stock Holding History

Raymond James & Associates’s Portfolio APHA Stock Details APHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,475
Closed -$266K – 4300
2021
Q1 		$266K Sell
14,475
-22,488
-61% -$364K ﹤0.01% 3437
2020
Q4 		$255K Buy
36,963
+4,293
+13% +$26.8K ﹤0.01% 3235
2020
Q3 		$145K Buy
32,670
+16,027
+96% +$74.9K ﹤0.01% 3310
2020
Q2 		$71K Sell
16,643
-14,293
-46% -$54.8K ﹤0.01% 3340
2020
Q1 		$94K Sell
30,936
-5,185
-14% -$20.7K ﹤0.01% 3231
2019
Q4 		$188K Buy
36,121
+19,907
+123% +$97.8K ﹤0.01% 3366
2019
Q3 		$84K Buy
16,214
+3,445
+27% +$21.9K ﹤0.01% 3407
2019
Q2 		$90K Buy
+12,769
New +$96.6K ﹤0.01% 3428

Raymond James & Associates's APHA Position: Q2 2021 in Review

Raymond James & Associates sold out of Aphria Inc. Common Shares (APHA) in Q2 2021, closing a stake of 14,475 shares — an estimated $266K sold.

Raymond James & Associates first reported a position in APHA in Q2 2019 and held it in 8 quarters. The position peaked at $266K in Q1 2021. 0 funds tracked by Wall St. Rank hold APHA as of Q2 2021.

  • Raymond James & Associates reported no remaining Aphria Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
  • Raymond James & Associates sold 14,475 Aphria Inc. Common Shares shares in Q2 2021, an estimated $266K.
  • Raymond James & Associates first reported a position in Aphria Inc. Common Shares in Q2 2019 and held it in 8 quarters.
  • Raymond James & Associates's Aphria Inc. Common Shares position peaked at $266K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Aphria Inc. Common Shares as of Q2 2021.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.